Literature DB >> 11535238

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study.

R J Caselli1, D Osborne, E M Reiman, J G Hentz, C J Barbieri, A M Saunders, J Hardy, N R Graff-Radford, G R Hall, G E Alexander.   

Abstract

In a previous cross-sectional study of 100 asymptomatic individuals aged 49-69, we reported age-related decline in immediate and delayed memory that was steeper in apolipoprotein E (apoE)-e4/4 homozygotes than in members of other genetic subgroups. These findings were preliminarily based upon the statistical problem of multiple comparisons. We therefore sought to replicate these findings in a new cohort. From 1998 to 2000, 80 asymptomatic residents of Maricopa County, AZ were recruited through newspaper ads. 20 apoE-e4/4 homozygotes, 20 e3/4 heterozygotes, and 40 e4 noncarriers were matched (1:1:2) by age, gender, and years of education. All had normal neurologic and psychiatric examinations, including Folstein minimental status exam (MMSE) and Hamilton depression scale, and underwent a battery of neuropsychological tests identical to those in our previous study. The groups were well-matched for age (55.9+/-5.9 years), gender (60% women), and education (15.9+/-2.2 years), and were demographically similar to our previous cohort. Complex figure test recall was lower in e3/4 heterozygotes than noncarriers, but there was no significant difference between e4/4 homozygotes and noncarriers. There were no other significant differences in mean test scores between groups, but Wechsler adult intelligence scale-revised (WAIS-R) digit span showed a significant negative correlation with age in the e4/4 homozygote group relative to e4 noncarriers (p=0.008) as we had found in our previous study. In conclusion, we found a significant negative correlation of WAIS-R digit span with age in apoE-e4/4 homozygotes relative to e4 noncarriers in two separate cohorts, possibly reflecting an age-related effect on frontal lobe function in this genetic subgroup.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11535238     DOI: 10.1016/s0022-510x(01)00577-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  22 in total

Review 1.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

2.  Asymmetry in auditory and spatial attention span in normal elderly genetically at risk for Alzheimer's disease.

Authors:  Mark W Jacobson; Dean C Delis; Mark W Bondi; David P Salmon
Journal:  J Clin Exp Neuropsychol       Date:  2005-02       Impact factor: 2.475

3.  Cognitive functions in low-grade gliomas: disease and treatment effects.

Authors:  Denise D Correa; Lisa M DeAngelis; Weiji Shi; Howard T Thaler; Michael Lin; Lauren E Abrey
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

4.  Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies.

Authors:  John V Pearson; Matthew J Huentelman; Rebecca F Halperin; Waibhav D Tembe; Stacey Melquist; Nils Homer; Marcel Brun; Szabolcs Szelinger; Keith D Coon; Victoria L Zismann; Jennifer A Webster; Thomas Beach; Sigrid B Sando; Jan O Aasly; Reinhard Heun; Frank Jessen; Heike Kolsch; Magdalini Tsolaki; Makrina Daniilidou; Eric M Reiman; Andreas Papassotiropoulos; Michael L Hutton; Dietrich A Stephan; David W Craig
Journal:  Am J Hum Genet       Date:  2006-12-06       Impact factor: 11.025

Review 5.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

6.  The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Authors:  Sterling C Johnson; Taylor W Schmitz; Mehul A Trivedi; Michele L Ries; Britta M Torgerson; Cynthia M Carlsson; Sanjay Asthana; Bruce P Hermann; Mark A Sager
Journal:  J Neurosci       Date:  2006-05-31       Impact factor: 6.167

7.  Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.

Authors:  Kewei Chen; Napatkamon Ayutyanont; Jessica B S Langbaum; Adam S Fleisher; Cole Reschke; Wendy Lee; Xiaofen Liu; Gene E Alexander; Dan Bandy; Richard J Caselli; Eric M Reiman
Journal:  Neuroimage       Date:  2012-02-12       Impact factor: 6.556

8.  In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.

Authors:  Sookjaroen Tangwongchai; Thitiporn Supasitthumrong; Solaphat Hemrunroj; Chavit Tunvirachaisakul; Phenphichcha Chuchuen; Natnicha Houngngam; Thiti Snabboon; Ittipol Tawankanjanachot; Yuthachai Likitchareon; Kamman Phanthumchindad; Michael Maes
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

9.  Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Authors:  Ingrid Reverte; Fiona Peris-Sampedro; Pia Basaure; Leticia Campa; Cristina Suñol; Margarita Moreno; José Luis Domingo; Maria Teresa Colomina
Journal:  Psychopharmacology (Berl)       Date:  2016-01       Impact factor: 4.530

10.  Apolipoprotein E epsilon4 influences on episodic recall and brain structures in aging pilots.

Authors:  Maheen M Adamson; Kelly M Landy; Susan Duong; Sabrina Fox-Bosetti; J Wesson Ashford; Greer M Murphy; Michael Weiner; Joy L Taylor
Journal:  Neurobiol Aging       Date:  2008-08-29       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.